ArticleGlobal health research and policy2024
Improving hypertension control in Nigeria: early policy implications from the Hypertension Treatment in Nigeria program.
Article in Global health research and policy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Implementation outcomes from the Hypertension Treatment in Nigeria program: results from a type 2 hybrid interrupted time series trial.Implementation science : IS · 2025Trial
- Cross-Sectional Associations of Dietary Pattern, Physical Activity with Hypertension Among Adults in Southwestern Nigeria.Nutrients · 2026Article
- Prevalence of hypertension, diabetes, and associated risk factors in a rural community in Western Kenya: a population-based cross-sectional survey.BMC public health · 2026Article
- Estimating investment costs to improve hypertension care in Lagos, Nigeria.Communications medicine · 2026Article
- Prevalence and predictors of hypertension among patients undergoing preanesthesia evaluation at Bahir Dar University Tibebe Ghion Specialized Hospital in 2025: a cross-sectional study.Perioperative medicine (London, England) · 2026Article
- The evolution of supportive supervision in low- and middle-income countries.BMC global and public health · 2026Review
- A Thematic Analysis of Key Informant Interviews on the Implementation Experience of the HEARTS Hypertension Program in Nigeria.Global heart · 2026Article
- Impact evaluation of the Hypertension Treatment in Nigeria program using the Translational Science Benefits Model.Journal of clinical and translational science · 2026Article
- Disease control and its correlates among hypertensive, diabetic, and asthmatic patients enrolled in secondary-level Integrated Chronic Care Clinics in Neno District, rural Malawi.PLOS global public health · 2026Article
- Capacity and site readiness for hypertension control program implementation in Nigeria: A nationwide cross-sectional study.PloS one · 2026Article
- Low physical activity-related disease burden, 1990-2021: assessment of global trends and social determinants based on GBD 2021 data.Journal of global health · 2025Article
- Design and implementation of a drug revolving fund for hypertension treatment in primary care setting of the Federal Capital Territory, Nigeria.BMJ global health · 2025Article
- Article
- Burden and Outcomes of Cardiovascular Diseases in the ICU of a Nigerian Tertiary Hospital.Cureus · 2025Article
- Unlocking health equity by eliminating copayments for essential antihypertensive medications.EClinicalMedicine · 2025Review
- Geo-demographic and socioeconomic determinants of diagnosed hypertension among urban dwellers in Ibadan, Nigeria: a community-based study.Journal of health, population, and nutrition · 2025Article
- Mapping the Dynamic Complexity of Hypertension Management in São Paulo, Brazil.International journal of public health · 2025Article
- Editorial: Global Excellence in Cardiovascular Medicine in Africa: challenges and opportunities.Frontiers in cardiovascular medicine · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Hypertension poses a significant health burden globally. In Nigeria, hypertension prevalence is on the rise, with low rates of awareness, treatment, and control. This policy brief explores the critical gaps addressed by the Hypertension Treatment in Nigeria (HTN) Program, highlighting its strengths, initial outcomes, and scalability in primary care settings. The HTN Program employs an integrated, multilevel care model based on the World Health Organization's HEARTS technical package, including patient registration and empanelment, team-based care, training and supervision, a standardized treatment protocol, a health information management system, and a drug revolving fund to improve medication accessibility. By December 2023, hypertension treatment and control rates reached surpassing 90% and 50%, respectively, thus underscoring the program's impact. The HTN Program serves as a model for delivering integrated hypertension care in primary care. Results should be leveraged for political commitment and financing to evaluate and manage non-communicable diseases such as hypertension in primary care through federal and state primary health development agencies. Furthermore, incorporating metrics related to hypertension control and treatment into the Integrated Supportive Management Information System can enhance routine monitoring and evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.